{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "1881021",
  "DateCompleted": {
    "Year": "1991",
    "Month": "09",
    "Day": "30"
  },
  "DateRevised": {
    "Year": "2013",
    "Month": "11",
    "Day": "21"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "8755-0059",
      "JournalIssue": {
        "Volume": "92",
        "Issue": "4",
        "PubDate": {
          "Year": "1991",
          "Month": "Apr"
        }
      },
      "Title": "Kansas medicine : the journal of the Kansas Medical Society",
      "ISOAbbreviation": "Kans Med"
    },
    "ArticleTitle": "Anticoagulants in heart disease.",
    "Pagination": {
      "StartPage": "114",
      "EndPage": "112",
      "MedlinePgn": "114, 112"
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Medicine, University of Kansas School of Medicine-Wichita 67214."
          }
        ],
        "LastName": "Vine",
        "ForeName": "D L",
        "Initials": "DL"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Kans Med",
    "NlmUniqueID": "8501226",
    "ISSNLinking": "8755-0059"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anticoagulants"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Platelet Aggregation Inhibitors"
    },
    {
      "RegistryNumber": "5Q7ZVV76EI",
      "NameOfSubstance": "Warfarin"
    },
    {
      "RegistryNumber": "9005-49-6",
      "NameOfSubstance": "Heparin"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "administration & dosage",
        "therapeutic use"
      ],
      "DescriptorName": "Anticoagulants"
    },
    {
      "QualifierName": [
        "blood",
        "complications",
        "drug therapy",
        "prevention & control"
      ],
      "DescriptorName": "Atrial Fibrillation"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Blood Coagulation"
    },
    {
      "QualifierName": [
        "blood",
        "complications",
        "drug therapy",
        "prevention & control"
      ],
      "DescriptorName": "Cardiomyopathy, Dilated"
    },
    {
      "QualifierName": [
        "blood",
        "complications",
        "drug therapy",
        "prevention & control"
      ],
      "DescriptorName": "Coronary Disease"
    },
    {
      "QualifierName": [
        "blood",
        "complications",
        "drug therapy"
      ],
      "DescriptorName": "Heart Diseases"
    },
    {
      "QualifierName": [
        "administration & dosage",
        "therapeutic use"
      ],
      "DescriptorName": "Heparin"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "administration & dosage",
        "therapeutic use"
      ],
      "DescriptorName": "Platelet Aggregation Inhibitors"
    },
    {
      "QualifierName": [
        "drug therapy",
        "etiology",
        "prevention & control"
      ],
      "DescriptorName": "Thromboembolism"
    },
    {
      "QualifierName": [
        "administration & dosage",
        "therapeutic use"
      ],
      "DescriptorName": "Warfarin"
    }
  ]
}